This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH), to The Emmes Company LLC, a global clinical research organization. The contract, valued at $13,756,583.42, is for the National Myelodysplastic Syndromes (MDS) Natural History Study, Data Coordinating Center (DCC), Task Order 03, from September 1, 2016 to February 28, 2018, with a potential completion date of December 31, 2025. The contract is a Cost Plus Award Fee type, and there was no set-aside designation. The Emmes Company LLC is a prime contractor for this award and has secured numerous other federal contracts and grants from various NIH institutes, demonstrating its expertise in supporting complex biomedical research initiatives.
Generated 3/15/25, 9:55 AM